Fig. 10From: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancerThree-dimensional structure (3D) related to the interaction between FGFR3 protein and approved drugs and candidate ligands after conducting molecular dynamics. Yellow color indicates molecular bonds (hydrogen and hydrophobic), blue color indicates approved drugs and green color was used to improve differentiate of molecular bondsBack to article page